Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

  • Scopus BioPharma (NASDAQ:SCPS) shares rose 72.1% to $1.1 during Monday's regular session. Trading volume for Scopus BioPharma's stock is 3.4 million as of 13:31 EST. This is 1745.6% of its average full-day volume over the last 100 days. The company's market cap stands at $23.2 million.
  • Yumanity Therapeutics (NASDAQ:YMTX) stock rose 47.32% to $1.65. Yumanity Therapeutics's stock is trading at a volume of 4.8 million shares as of 13:31 EST. This is 5342.2% of its average full-day volume over the last 100 days. The company's market cap stands at $17.0 million.
  • GBS (NASDAQ:GBS) shares increased by 37.25% to $1.14. Trading volume for GBS's stock is 5.8 million as of 13:31 EST. This is 253.2% of its average full-day volume over the last 100 days. The company's market cap stands at $16.9 million.
  • Corbus Pharmaceuticals (NASDAQ:CRBP) shares moved upwards by 34.79% to $0.44. Corbus Pharmaceuticals's stock is trading at a volume of 3.6 million shares as of 13:31 EST. This is 303.9% of its average full-day volume over the last 100 days. The company's market cap stands at $55.7 million.
  • Spectrum Pharmaceuticals (NASDAQ:SPPI) stock moved upwards by 33.08% to $1.2. As of 13:31 EST, Spectrum Pharmaceuticals's stock is trading at a volume of 7.0 million, which is 129.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $210.8 million. The company's, Q4 earnings came out 2 days ago.
  • NexGel (NASDAQ:NXGL) shares rose 19.25% to $2.04. As of 13:31 EST, this security is trading at a volume of 186.8K shares, making up 45.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $11.3 million. The company's, Q4 earnings came out today.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.